Labcorp added to its suite of tests designed to detect cancer recurrence much earlier than traditional imaging.
For the full fiscal year 2025, Wall Street analysts expect Labcorp’s diluted EPS to grow by 12% annually to $16.32, followed ...
PracticeQ and Fullscript partner to simplify lab ordering and results management, helping providers deliver faster, more connected care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback